Success Metrics

Clinical Success Rate
69.2%

Based on 9 completed trials

Completion Rate
69%(9/13)
Active Trials
10(30%)
Results Posted
22%(2 trials)
Terminated
4(12%)

Phase Distribution

Ph not_applicable
14
42%
Ph phase_2
9
27%
Ph phase_3
1
3%
Ph early_phase_1
2
6%
Ph phase_1
7
21%

Phase Distribution

9

Early Stage

9

Mid Stage

1

Late Stage

Phase Distribution33 total trials
Early Phase 1First-in-human
2(6.1%)
Phase 1Safety & dosage
7(21.2%)
Phase 2Efficacy & side effects
9(27.3%)
Phase 3Large-scale testing
1(3.0%)
N/ANon-phased studies
14(42.4%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

69.2%

9 of 13 finished

Non-Completion Rate

30.8%

4 ended early

Currently Active

10

trials recruiting

Total Trials

33

all time

Status Distribution
Active(12)
Completed(9)
Terminated(4)
Other(8)

Detailed Status

Recruiting10
Completed9
unknown8
Terminated4
Not yet recruiting2

Development Timeline

Analytics

Development Status

Total Trials
33
Active
10
Success Rate
69.2%
Most Advanced
Phase 3

Trials by Phase

Early Phase 12 (6.1%)
Phase 17 (21.2%)
Phase 29 (27.3%)
Phase 31 (3.0%)
N/A14 (42.4%)

Trials by Status

completed927%
unknown824%
not_yet_recruiting26%
terminated412%
recruiting1030%

Recent Activity

Clinical Trials (33)

Showing 20 of 33 trialsScroll for more
NCT05753774Phase 3

Effect of Fecal Microbiota Transplantation (FMT) in Pediatric Functional Gastrointestinal Disorders

Terminated
NCT05739864Phase 1

Superdonor FMT in Patients With Ulcerative Colitis

Recruiting
NCT05740319Not Applicable

Efficacy and Safety Evaluation of Fecal Microbiota Transplantation in Irritable Bowel Syndrome

Recruiting
NCT07387952Not Applicable

The Safety and Efficacy of Fecal Microbiota Transplantation Combined With Nutritional Intervention in the Treatment of Functional Constipation:a Pilot Study

Recruiting
NCT07386795Not Applicable

The Efficacy and Safety of Microbiota Transplantation Combined With Prebiotics for Treatment of Functional Constipation

Not Yet Recruiting
NCT07153809Not Applicable

Fecal Microbiota Transplantation (FMT) in Patients With Moderate to Severe Acute Pancreatitis

Recruiting
NCT05257538Not Applicable

FMT in Initial CDI

Recruiting
NCT04970446Phase 1

Microbial Restoration in Inflammatory Bowel Diseases

Recruiting
NCT01793831Not Applicable

Standardized Fecal Microbiota Transplantation for Crohn's Diseases

Recruiting
NCT06496191Not Applicable

FMT for Alcohol Use Disorder in Cirrhotics.

Recruiting
NCT06451588Phase 2

Fecal Microbiota Transplantation in Axial Spondyloarthritis

Recruiting
NCT06250413Not Applicable

Autoflor -Lyophilized Capsulated Autological FMT to Restore Gut Microbiome After Treatment With Antibiotics

Not Yet Recruiting
NCT02255305Phase 2

FMT Versus Antimicrobials for Initial Treatment of Recurrent CDI

Terminated
NCT04146337Phase 2

Fecal Microbiota Transplantation for Carbapenem-resistant Enterobacteriaceae

Completed
NCT04790565Phase 2

Fecal Microbiota Transplantation for Carbapenem Resistant Enterobacteriaceae

Completed
NCT03439982Phase 1

Fecal Transplant for Hepatic Encephalopathy

Completed
NCT05361785Not Applicable

Fecal Microbiota Transplantation for Irritable Bowel Syndrome Associated Food Intolerance

Recruiting
NCT03477916Phase 2

Fecal Microbial Transplantation and Fiber Supplementation in Participants With Obesity and Metabolic Syndrome.

Completed
NCT03720392Phase 2

Fecal Microbiota Transplantation (FMT) in Recipients After Allogeneic Hematopoietic Cell Transplantation (HCT)

Terminated
NCT04142255Early Phase 1

Explore Efficacy of FMT Treating Childhood ASD Patients

Terminated

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
33